Safety of omalizumab administration in chronic spontaneous urticaria
during COVID-19 infection: a case report.
- Marisa Paulino,
- Célia Costa,
- Elisa Pedro
Marisa Paulino
Centro Hospitalar Universitario Lisboa Norte EPE
Corresponding Author:marisapaulino.90@gmail.com
Author ProfileCélia Costa
Centro Hospitalar Universitario Lisboa Norte EPE
Author ProfileElisa Pedro
Centro Hospitalar Universitario Lisboa Norte EPE
Author Profile
